Q&M Group awards 7 dentists with Performance Shares,12-year Service Agreements, and a Private Placement

SINGAPORE, Sep 30, 2022 - (ACN Newswire via SEAPRWire.com) - Mainboard-listed Q&M Dental Group (Singapore) Limited [SGX: QC7] announced on 29 September 2022 the award of 2,014,245 shares to 7 promising next-generation dentists as part of the Q&M Performance Share Plan (PSP) 2018, as well as the proposed placement of…

Restricted Shares Will be Lifted on 22 September, and the Management and Investors of Arrail Group are “Hoarding”, Release High Growth Signals

HONG KONG, Sep 22, 2022 - (ACN Newswire via SEAPRWire.com) - The restricted shares of Arrail Group Limited ("Arrail Group" or the "Company", stock code: 06639.HK), a leading dental services group in China, will be officially lifted and listed for circulation on 22 September 2022. In this regard, the Company's…

Q&M Dental net profit, excluding other gains or losses, increased by 25% to S$7.2 million on S$46.8 million of revenue for quarter ended 31 March 2022

SINGAPORE, May 12, 2022 - (ACN Newswire via SEAPRWire.com) - Q&M Dental Group (Singapore) Limited, a leading private dental healthcare group in Asia, reported net profit excluding other gains or losses attributable to shareholders of S$7.2 million for the quarter ended 31 March 2022 (1Q2022) compared to S$5.8 million in…

CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021

– EBITDA grew 47% for 12 months ended 31 Dec 2021– Proposed listing of 49%-owned Acumen Diagnostics on NASDAQ will enhance AOXIN’s shareholder value– Growth trend in revenue expected to continue as COVID-19 situation in China improves SINGAPORE, Feb 23, 2022 – (ACN Newswire) – Catalist listed Aoxin Q&M Dental Limited (“Aoxin” or “the…

Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%

– Revenue increases by 49% to S$205.6 million and Profit After Tax increases by 98% to S$39.4 million for FY2021– Core dental and medical clinics segment continues strong growth with 27% increase in revenue for FY2021– Declares fourth interim dividend of 1.0 Singapore cent per ordinary share for 4Q2021, giving…

Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide

SINGAPORE, Dec 16, 2021 - (ACN Newswire via SEAPRWire.com) - Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited ("Q&M Dental") and 49% owned by Aoxin Q&M Dental Group Limited ("Aoxin Q&M Dental"), today announced that…